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ABSTRACT 
Arginine is a conditionally essential amino acid that is involved in protein synthesis, the 
detoxification of ammonia, and its conversion to glucose as well as being catabolized to produce 
energy.  In addition to these physiological functions, arginine has been purported to have ergogenic 
potential.  Athletes have taken arginine for three main reasons: 1) its role in the secretion of 
endogenous growth hormone; 2) its involvement in the synthesis of creatine; 3) its role in 
augmenting nitric oxide.  These aspects of arginine supplementation will be discussed as well as a 
review of clinical investigations involving exercise performance and arginine ingestion.  Journal of 
the International Society of Sports Nutrition.  1(2):35-38, 2004  
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INTRODUCTION 
 
Arginine is a basic amino acid and is 
classified as a conditionally essential amino 
acid.  The typical dietary intake of arginine 
is 3.5 to 5 grams daily 
1.  One of the main 
functions of arginine is its participation in 
protein synthesis 
2,3.  Also, arginine is 
involved in a number of other roles in the 
body such as the detoxification of ammonia 
formed during the nitrogen catabolism of 
amino acids via the formation of urea 
1; its 
potential to be converted to glucose  (hence 
its classification as a glycogenic amino 
acid); and its ability to be catabolized to 
produce energy 
1.  Arginine is utilized by a 
number of metabolic pathways that produce 
a variety of biologically active compounds 
such as nitric oxide, creatine, agmatine, 
glutamate, polyamines, ornithine, and 
citrulline 
2,3.   
 
In addition to these physiological functions, 
arginine has been purported to have 
ergogenic potential.  Athletes have taken 
arginine for three main reasons: 1) its role in 
the secretion of endogenous growth 
hormone 
4; 2) its involvement in the 
synthesis of creatine; 3) its role in 
augmenting nitric oxide.  The focus of this 
review will be to investigate these various 
ergogenic possibilities and to examine the 
investigations that have looked at arginine 
supplementation and exercise performance.   
 
ARGININE AND GROWTH 
HORMONE 
 
It is well documented that the infusion of 
arginine stimulated growth hormone 
secretion from the anterior pituitary 
5-7.  This 
increase in growth hormone secretion from 
arginine infusion has been attributed to the 
suppression of endogenous somatostatin 
secretion 
8.  The amounts of arginine infused 
to elicit the growth hormone response 
ranged from 12 grams to 30 grams.  The 
clinical investigations of oral consumption 
of arginine and its impact on growth 
hormone release are not in agreement.  
When arginine (1.2g) was ingested along 
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males, peak plasma growth hormone 
concentrations increased 8-fold at 90 
minutes post-ingestion 
9.  However, when 
arginine and lysine were ingested alone at 
the same doses, there was no corresponding 
increase in plasma growth hormone.  
Suminiski and associates 
10 reported that the 
ingestion of arginine (1.5g) and lysine (1.5g) 
resulted in a 2.7-fold increase in plasma 
growth hormone concentrations in resistance 
trained males.  Colombani et al. 
11 
supplemented marathon runners with 15g 
arginine aspartate for 14 days before a 
marathon run.  On the day of the marathon, 
blood samples were taken shortly before the 
run, after 31km, at the end of the run, and 
after a recovery period of two hours.  The 
researchers found that growth hormone 
concentrations were elevated during a 
marathon run to a greater degree than 
exercise would elicit alone.  
 
Other studies using either resistance trained 
or physically active individuals showed no 
increases in plasma growth hormone 
concentrations following arginine 
supplementation.  When resistance trained 
males consumed approximately 8 grams of 
arginine daily for 17 days there was no 
associated changes in growth hormone 
concentrations 
12.  Similarly, Lambert et al. 
13 gave male bodybuilders 1.2g of arginine 
and 1.2g of lysine.  This supplementation 
did not induce a statistically significant 
increase in serum growth hormone 
concentrations over a 3 hour period.  In a 
recent review, Chromiak and Antonio 
4 
highlighted several factors that appear to 
modify the growth hormone response to 
amino acid administration.  These include 
training status, age, sex, diet, and time since 
last meal.  Also, the growth hormone 
response to amino acid ingestion may be 
reduced in exercise-trained individuals 
4.  
These authors concluded that the practice of 
consuming specific amino acids, including 
arginine, during or after exercise does not 
appear to be effective 
4.   
 
 
ARGININE AND CREATINE 
 
Another possible ergogenic potential of 
arginine is its role in the synthesis of 
creatine.  Arginine, glycine, and methionine 
are the three amino acids involved in the 
synthesis of creatine.  Creatine has been 
shown to increase muscular strength 
14 and 
muscle fiber size 
15.  In addition, creatine 
supplementation enhances performance in 
swimming, all out cycling, sprinting, 
repeated jumping, and resistance training 
16.  
It is worth noting that these improvements in 
muscle function and exercise performance 
were the result of creatine supplementation.  
A question to be asked is whether an 
increase in dietary or supplemental arginine 
results in an increase in creatine stores to the 
levels observed where there was 
performance enhancement.  Do to the fact 
that the rate limiting step in the synthesis of 
creatine from arginine and glycine is the 
formation of guanidinoacetate by the 
enzyme arginine:glycine amidino-transferase 
(AGAT) 
17 and not arginine concentration; 
furthered by the fact that dietary creatine 
ingestion downregulates AGAT 
18, it is 
unlikely that additional arginine ingestion 
leads to increases in creatine concentration 
needed to improve performance.  Rather, the 
most likely method of increasing 
performance from increases in creatine 
stores is from supplemental creatine or 
increasing dietary creatine.   
 
ARGININE AND NITRIC OXIDE 
 
Arginine is a precursor of the cell-signaling 
molecule nitric oxide (NO).  NO acts as a 
signaling molecule to facilitate the dilation 
of blood vessels and decrease vascular 
resistance.  NO is synthesized from arginine 
under the enzymatic control of nitric oxide 
synthase (NOS).  There are three NOS 
isoforms, endothelial cell NOS (eNOS), 
neuronal NOS (nNOS), and inducible NOS 
(iNOS).  Skeletal muscle expresses all three 
forms of NOS, with nNOS predominating.  
Muscle functions regulated by NO or related 
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(excitation-contraction coupling), 
autoregulation of blood flow, myocyte 
differentiation, respiration, and glucose 
homeostasis 
19.  Contractile activity greatly 
increases NO production in the muscle, and 
this is likely due to elevated intracellular 
calcium 
20.  One of the main effects of NO 
on skeletal muscle metabolism is to increase 
the delivery and uptake of fuel substrates via 
its vasodilating effects 
21.  Even though 
arginine augments nitric oxide production, 
there is still no clear evidence that this 
synthesis of nitric oxide results in 
improvements in exercise performance in 
healthy individuals.   
 
ARGININE AND EXERCISE 
PERFORMANCE 
 
With all of the aforementioned effects that 
arginine possesses in relation to ergogenic 
potential, it would seem plausible that 
supplementing with arginine would improve 
exercise performance and body composition.  
There is scant evidence that this is the case 
in humans, and the available data is 
conflicting.  When male weight trainers on a 
hypocaloric diet ingested approximately 8 
grams of arginine daily, there were no 
positive influences on muscle function 
(biceps/quadriceps isokinetic assessments) 
or body composition 
12.  Conversely, when 
untrained males were given 3 grams of 
arginine daily for 15 days and underwent a 
test retest protocol evaluating resistance to 
muscular fatigue (by quadriceps isokinetic 
dynamometry), there was a significant 
resistance to muscular fatigue 
22.  
Unfortunately, the investigators did not 
utilize a double-blinded protocol nor was 
there a placebo or control group.   
 
In addition to the studies conducted on 
healthy subjects, there are also several 
studies investigating the effects of oral 
arginine supplementation in subjects with 
cardiovascular issues 
23-25.  Subjects with 
congestive heart failure ingested 9 grams of 
arginine daily for 7 days.  At the end of the 
supplementation period, the authors 
concluded that in patients with chronic 
stable congestive heart failure, 
supplementation with a moderate dose of 
arginine resulted in a prolonged exercise 
duration as compared to placebo 
23.  In 
patients with healed myocardial infarction, 
investigators 
24 supplemented the 
participants with 6 grams of arginine for 3 
days.  After only 3 days of such 
supplementation, the authors concluded that 
oral arginine supplementation had a 
beneficial effect on exercise capacity in 
patients with stable angina.   
Nagaya, et al. 
25  studied the effects of oral 
supplementation of arginine on exercise 
capacity in patients with pulmonary 
hypertension.  Cardiorespiratory exercise 
tests were performed to measure peak 
oxygen consumption.  The supplementation 
protocol required that each treated subject 
consume 1.5 g of arginine per 10 kg of body 
weight per day for 7 days.  A significant 
increase in peak oxygen consumption was 
observed.  A possible mechanism to describe 
this increase in performance is the role that 
arginine has in augmenting nitric oxide.  An 
increase in nitric oxide bioavailability results 
in coronary vessel vasodilatation and flow, 
which in turn may positively influence 
coronary perfusion. 
 
CONCLUSION 
 
Arginine’s involvement as a precursor of 
creatine and its potential to increase 
endogenous growth hormone makes it a 
popular supplement among those who wish 
to improve their physical performance.  The 
choice to supplement with arginine is also 
based on sound physiologic theory.  
However, there is currently little scientific 
evidence available to support such claims 
promoting and increase in functional 
capacity in healthy, athletic participants.  
Among those with cardiovascular issues 
(congestive heart failure, healed myocardial 
infarction, and pulmonary hypertension) 
there does seem to be some rational for 
ingesting arginine (3-9g/day) for an 
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These improvements may be accounted for 
via arginine’s role as a precursor to nitric 
oxide.  More research is needed to evaluate 
the role of arginine supplementation on 
exercise performance and training 
adaptations in healthy and diseased 
populations before any conclusions can be 
drawn. 
 
REFERENCES 
 
1.       PDR for Nutritional Supplements, Montvale, NJ: Thompson PDR.; 2001 
2.       Tong BC, Barbul, A. Cellular and physiological effects of arginine. Mini Reviews in Medicinal Chemistry 2004;4(8):823-32. 
3.       Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998;336:1-17. 
4.       Chromiak JA, Antonio J. Use of amino acids as growth hormone-releasing agents by  athletes. Nutrition 2002;18(7/8):657-661. 
5.       Merimee TJ, Rabinowitz D, Riggs L, et al. Plasma growth hormone after arginine infusion. Clinical experiences. N Engl J Med  
          1967;276(8):434-9. 
6.       Merimee TJ, Rabinowitz D, Fineberg SE. Arginine-initiated release of human growth hormone. Factors modifying the  
          response in normal man. N Engl J Med 1969;280(26):1434-8. 
7.       Hembree WC, Ross GT. Arginine infusion and growth-hormone secretion.  Lancet 1969;1(7584):52. 
8.       Alba-Roth J, Muller OA, Schopohl J, et al. Arginine stimulates growth hormone secretion by suppressing endogenous  
          somatostatin secretion. J Clin Endocrinol Metab 1988;67(6):1186-9. 
9.       Isidori A, Lo Monaco A, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Curr  
          Med Res Opin 1981;7(7):475-81. 
10.     Suminiski RR, Robertson RJ, Goss FL, et al. Acute effect of amino acid ingestion and resistance exercise on plasma growth  
          hormone concentration in young men. Int J Sport Nutr 1997;7:48-60. 
11.     Colombani PC, Bitzi R, Frey-Rindova P, Frey W, et al. Chronic arginine aspartate supplementation in runners reduces total  
          plasma amino acid level at rest and during a marathon run. Eur J Nutr 1999;38:263-70. 
12.     Walberg-Rankin J, Hawkins C, et al. The effect of oral arginine during energy restriction in male weight trainers. J Strength  
          Cond Res 1994;8(3):170-7. 
13.     Lambert MI, Hefer JA, Millar RP, Macfarlane PW. Failure of commercial oral amino acid supplements to increase serum  
          growth hormone concentrations in male bodybuilders. Int J Sport Nutr 1993;3:298. 
14.     Vandenberghe k, Goris M, Van Hecke P, Van Leemputte M, et al. Long-term creatine intake is beneficial to muscle  
          performance and pharmacokinetic considerations. J Appl Physiol 1997;83:2055-2063. 
15.     Volek JS, Duncan ND, Mazzetti SA, Putukian M. Performance and muscle fiber adaptations to creatine supplementation and  
          heavy resistance training. Med Sci Sports Exerc 1999;31:1147-1156. 
16.     Juhn MS, Tarnopolsky M. Oral creatine supplementation and athletic performance: A critical review. Clin J Sport Med  
          1998;8:286-297. 
17.     Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol 1979;50:177-242. 
18.     Stead LM, Au KP, Jacobs RL, Brosnan ME, et al.  Methylation demand and homocysteine metabolism: effects of dietary  
          provision of creatine and guanidineacetate.  Am J Physiol 2001;281:E1095-E1100. 
19.     Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001;81(1):209-237. 
20.     Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric-oxide in skeletal muscle. Nature 1994;372(6506):546-548. 
21.     Wolin MS, Hintze TH, Shen W, Hohazzabh KM, et al. Involvement of reactive oxygen and nitrogen species in signaling  
          mechanisms that control tissue respiration in muscle. Biochem Sos Trans 1997;25(3):934-939. 
22.     Santos RS, Pacheco MTT, Martins RABL, Villaverde AB, et al. Study of the effect of oral administration of L-arginine on  
          muscular performance in healthy volunteers: an isokinetic study. Isokinetics and Exercise Science 2002;10(3):153-158. 
23.     Bednarz B, Jaxa-Chamiec T, Gebalska J, Herba K, et al. L-arginine supplementation prolongs duration of exercise in  
          congestive heart failure. Polish Heart Journal 2004;60(4):348-353 
24.     Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients  
          with stable angina pectoris.  Am J Cardiol 1997;80(3):331-333. 
25.     Nagaya N, Uematsu M, Oya H, Sato N, et al. Short-term oral administration of L-arginine improves hemodynamics and  
          exercise capacity in patients with precapillary pulmonary hypertension.  Am J Respir Crit Care Med 2001;163:887-891. 
 
 
 